Accessibility Menu
 
Instem Plc logo

Instem Plc

(LSE) INS

Current PriceN/A
Market CapN/A
Since IPO (2010)+349%
5 Year+244%
1 Year+22%
1 Month+10%

Instem Plc Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$101.48M

Net Income (TTM)

$4.20M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

INS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Instem Plc

Industry

Health Care Technology

CEO

Philip John Reason

Headquarters

Stone, ST15 0SD, GB

INS Financials

Key Financial Metrics (TTM)

Gross Margin

42%

Operating Margin

12%

Net Income Margin

8%

Return on Equity

9%

Return on Capital

13%

Return on Assets

5%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$24.44M

Operating Income

$7.23M

EBITDA

$10.83M

Operating Cash Flow

$7.87M

Capital Expenditure

$3.51M

Free Cash Flow

$4.36M

Cash & ST Invst.

$13.96M

Total Debt

$1.30M

Instem Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

$29.74M

+131.3%

Gross Profit

$11.50M

+90.0%

Gross Margin

38.67%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

500

N/A

Net Income

$31.00K

+93.3%

EBITDA

$3.15M

+89.2%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Net Cash

$6.78M

-56.2%

Accounts Receivable

$15.41M

+25.3%

Inventory

$91.00K

+68.5%

Long Term Debt

$322.00K

-75.5%

Short Term Debt

$1.57M

+46.0%

Return on Assets

5.07%

N/A

Return on Invested Capital

12.50%

N/A

Free Cash Flow

$1.36M

-31.8%

Operating Cash Flow

$1.42M

-47.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ARIX.LArix Bioscience plc
$142.00-1.05%
MXCT.LMaxCyte, Inc.
$147.69-7.69%
MGP.LMedica Group Plc
$212.00+0.47%
SMD.LSpectral MD Holdings, Ltd.
$58.00+10.48%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.87-0.04%
HOLXHologic
$76.01+0.00%
NOKNokia
$8.89+0.01%
INTCIntel
$50.78+0.01%

Questions About INS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.